Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bristol, TN
NPI
1295053759
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
240 Medical Park Blvd, Ste 3800
Bristol, TN, 37620
Phone (423) 990-2424
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
1,049 services
Medicare patients, 2024
398
Average age 70
Drug cost, 2024
$2.9M
5,272 prescriptions
Company payments, 2025
$1,803
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan C Kennedy was code 99214 (office e&m - established), 723 times for 348 patients. In total Ryan C Kennedy billed 1,049 services in 9 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 723 | 348 | $84.23 | $61K |
| 95251 Test - Miscellaneous | Office | 221 | 99 | $24.24 | $5,357 |
| 99204 Office E&M - New | Office | 71 | 71 | $104.63 | $7,429 |
| 36415 Venipuncture Blood Collection | Office | 16 | 16 | $8.65 | $138 |
By year: 2022 $65K for 940 services; 2023 $70K for 978 services; 2024 $75K for 1,049 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 16 | $8.65 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Ryan C Kennedy prescribed most often to Medicare patients was Levothyroxine Sodium, with 631 prescriptions and refills. In total Ryan C Kennedy wrote 5,272 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 631 | 1,749 | 182 | $43K |
| Mounjaro Tirzepatide | 414 | 525 | 85 | $536K |
| Metformin Hcl Er Metformin Hcl | 239 | 648 | 76 | $3,363 |
| Synthroid Levothyroxine Sodium | 232 | 567 | 52 | $19K |
| Ozempic Semaglutide | 207 | 352 | 67 | $335K |
| Tresiba Flextouch U-200 Insulin Degludec | 149 | 320 | 42 | $230K |
| Novolog Insulin Aspart | 119 | 266 | 31 | $59K |
| Novolog Flexpen Insulin Aspart | 111 | 228 | 42 | $31K |
| Jardiance Empagliflozin | 109 | 214 | 32 | $123K |
| Methimazole Generic | 105 | 274 | 34 | $1,074 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 103 | 197 | 27 | $21K |
| Humalog Insulin Lispro | 84 | 204 | 24 | $40K |
| Metformin Hcl Generic | 84 | 208 | 24 | $533 |
| Rosuvastatin Calcium Generic | 80 | 232 | 28 | $1,135 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 70 | 122 | 20 | $79K |
Brand drugs: 2,957 claims; generic drugs: 1,890 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan C Kennedy $1,803 ($1,803 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $257.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.